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Abstract
Background: Malaria in pregnancy can have devastating consequences for mother and baby. Coverage with the WHO
prevention strategy for sub-Saharan Africa of intermittent-preventive-treatment (IPTp) with two doses of sulphadoxine-
pyrimethamine (SP) and insecticide-treated-nets (ITNs) in pregnancy is low. We analysed household survey data to evaluate
the effectiveness of antenatal clinics (ANC) to deliver IPTp and ITNs to pregnant women in Nyando district, Kenya.
Methods: We assessed the systems effectiveness of ANC to deliver IPTp and ITNs to pregnant women and the impact on
low birthweight (LBW). Logistic regression was used to identify predictors of receipt of IPTp and ITN use during pregnancy.
Results: Among 89% of recently pregnant women who attended ANC at least once between 4–9 months gestation, 59%
reported receiving one dose of SP and 90% attended ANC again, of whom 57% received a second dose, resulting in a
cumulative effectiveness for IPTp of 27%, most of whom used an ITN (96%). Overall ITN use was 89%, and ANC the main
source (76%). Women were less likely to receive IPTp if they had low malaria knowledge (0.26, 95% CI 0.08–0.83), had a child
who had died (OR 0.36, 95% CI 0.14–0.95), or if they first attended ANC late (OR 0.20, 95% CI 0.06–0.67). Women who
experienced side effects to SP (OR 0.18, CI 0.03–0.90) or had low malaria knowledge (OR 0.78, 95% CI 0.11–5.43) were less
likely to receive IPTp by directly observed therapy. Ineffective delivery of IPTp reduced its potential impact by 231 LBW cases
averted (95% CI 64–359) per 10,000 pregnant women.
Conclusion: IPTp presents greater challenges to deliver through ANC than ITNs in this setting. The reduction in public
health impact on LBW resulting from ineffective delivery of IPTp is estimated to be substantial. Urgent efforts are required to
improve service delivery of this important intervention.
Citation: Hill J, Dellicour S, Bruce J, Ouma P, Smedley J, et al. (2013) Effectiveness of Antenatal Clinics to Deliver Intermittent Preventive Treatment and Insecticide
Treated Nets for the Control of Malaria in Pregnancy in Kenya. PLoS ONE 8(6): e64913. doi:10.1371/journal.pone.0064913
Editor: Lorenz von Seidlein, Menzies School of Health Research, Australia
Received March 14, 2013; Accepted April 19, 2013; Published June 14, 2013
This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for
any lawful purpose. The work is made available under the Creative Commons CC0 public domain dedication.
Funding: This work was supported by the Malaria in Pregnancy (MiP) Consortium, which is funded through a grant from the Bill & Melinda Gates Foundation to
the Liverpool School of Tropical Medicine, United Kingdom. The funders had no role in study design, data collection and analysis, decision to publish, or
preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: j.hill@liv.ac.uk
Background
Malaria in pregnancy can have devastating consequences for
both mother and baby, yet the harmful effects are preventable [1].
In 2007, approximately 32 million pregnancies occurred in
malaria-endemic areas in sub-Saharan Africa [2]. The World
Health Organisation’s (WHO) recommended strategy for malaria
prevention and control during pregnancy in areas of stable malaria
transmission in Africa is a package of intermittent preventive
treatment (IPTp) with two doses of sulphadoxine–pyrimethamine
(SP), regular use of insecticide treated nets (ITNs), and effective
management of clinical malaria and anaemia. These interventions
are commonly delivered through antenatal clinics (ANC) through
a collaboration between malaria and reproductive health pro-
grammes [3]. IPTp and ITNs can substantially reduce disease
burden and adverse outcomes of malaria in pregnancy [4–7], and
are inexpensive and cost effective [5,6,8]. The Roll Back Malaria
Partnership (RBM) aims to ensure that 100% pregnant women
receive IPTp and at least 80% of people at risk from malaria
(including pregnant women) use ITNs in areas of moderate to
high-intensity transmission by 2010 [9], with even more ambitious
targets of 100% for both interventions by 2015 [10] and a call for
universal ITN coverage [11].
In spite of almost universally high levels of ANC coverage in
countries of sub-Saharan Africa (SSA) [12], coverage with the
WHO recommended two doses of SP and ITNs in the majority of
countries is extremely low. According to a recent review of
national survey data in 27 countries with survey data between the
years 2009–2011, median coverage of two doses of SP was 24.5%
(range 7.3–69.4%) even though the median ANC coverage for at
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least two visits was 84.6% (range 49.7–96.9%, 22 countries, 2003–
2011) [13] representing substantial missed opportunities at ANC.
Despite all 45 malaria endemic countries having a policy of
providing ITNs to pregnant women, the median use of an ITN the
previous night among pregnant women in 37 countries with survey
data between the years 2009–2011 was 35.3%, range 5.2–75.5
[13].
The RBM and other global health targets such as the
Millennium Development Goals will not be met unless programme
managers can measure, identify, and address the current barriers
to the delivery of IPTp and ITNs. It is a particular concern that
programmes have been unable to deliver IPTp effectively [14,15],
as this relatively simple and cost effective regimen will most likely
be replaced with more complicated and expensive drug regimens
or new strategies [16] in the near future due to increasing
resistance to SP [5,17]. These alternative prevention strategies will
present even greater challenges for effective delivery or systems
effectiveness [18,19].
Whilst the number of studies that have explored the determi-
nants of the uptake of IPTp and ITNs among pregnant women
and/or providers has increased substantially in recent years [20],
few have attempted to measure the effectiveness of the delivery
system or to quantify and compare the relative impact of missed
opportunities at ANC [21–23]. A better understanding of the
relative impact of the different factors on the delivery of these
important interventions will help policy makers achieve the best
value for money when considering which barriers to target in
efforts to improve uptake. This study measured the effectiveness of
implementation of the national policy to deliver both IPTp and
ITNs to pregnant women through ANC in one district in Kenya,
including the effect on the frequency and timing of ANC visits,
and assessed the predictors of effective delivery.
Methods
Study Area
This household survey was conducted as part of a larger study to
identify and quantify the major barriers to the scale up and use of
interventions to control malaria in pregnancy at the district,
facility, and community level. The study was conducted in Greater
Nyando District (now divided into Nyando, Muhoroni and
Nyakach districts) in Nyanza Province, Kenya, between February
and March 2010. Greater Nyando District has a population of
355,800 (1999 census), with more than 90% living in rural areas.
Malaria is perennial holo-endemic with a parasite prevalence of
8.3% among women of child bearing age (2008 unpublished data,
KEMRI/CDC), peaking between April to June and October to
December. HIV prevalence among women aged 15–49 years is
higher in Nyanza Province compared to all other provinces in the
country, 18% compared to national average of 9% [24].
Greater Nyando had a total of 40 health facilities of which 60%
(24) were owned by government, 13% (5) by missions, 18% (7)
privately owned and 10% (4) community run. The government
facilities comprised 1 hospital, 2 sub-district hospitals, 6 health
centres and 15 dispensaries, the mission owned 1 hospital, 3 health
centres and 1 dispensary and the community owned 4 dispensa-
ries.
In line with WHO recommendations on focussed antenatal care
(FANC), national policy in Kenya is for pregnant women to
receive a package of interventions through antenatal care at each
of 4 recommended ANC visits. Malaria in pregnancy interventions
are delivered alongside prevention and control of mother to child
transmission of HIV (PMTCT), tuberculosis, syphilis/sexually
transmitted infections, palpations and birth planning. Malaria
services include a free long-lasting insecticide treated net (LLIN)
provided to all women at their first ANC visit, a minimum of two
doses of SP taken under DOT and prompt diagnosis and
treatment of malaria episodes with an effective antimalarial
alongside health education at ANC [25]. According to current
national guidelines, the first dose of SP should be given to all
women after quickening and subsequent dose(s) taken at least 4
weeks (one month) apart. HIV positive pregnant women taking
daily cotrimoxazole should not be given IPTp-SP [25,26].
Kenya adopted IPTp policy in 1999, followed by the delivery of
ITNs to pregnant women through ANC in 2001. National level
DHS data available at the time the study was designed (DHS
2003) showed that 84% of women made two or more ANC visits,
4% pregnant women received two doses of SP during ANC visits
and 4% of pregnant women used an ITN the night before the
survey [24]. The IPTp and ITN coverage figures for Nyanza
Province were marginally higher than the national average, with
5% reporting having received two doses of IPTp and 9% pregnant
women reporting having used an ITN the night before the survey.
Study Design and Selection of Study Participants
A two stage cluster sampling household survey was undertaken
over 3 weeks during a period of intense rains, between February
and March 2010. Enumeration areas from the 1999 census were
used to select 40 villages, representing clusters, using probability
proportional to size. A sample size of 338 women of child-bearing
age (15–49 years) was sufficient to estimate an IPTp or ITN uptake
of 50%, with a 6% precision, design effect of 1.75 and 10% non-
response. The sample size was increased to 1,120 to maintain
precision in a range of intermediate processes in the delivery of
IPTp and ITNs with decreasing sample size, where women are lost
from the evaluable sample at different points [27], and uses the
hypothetical assumptions that 60% of women attending ANC are
offered an ITN, of which 50% then use the ITN.
Households in selected clusters were mapped using Global
Positioning System (GPS) software (CDC GPS Sample for
Windows Mobile devices https://sites.google.com/a/wolkon.
com/gps-sample/). Thirty five households were randomly selected
from GPS coordinates of all households within each cluster to get
28 households with women of childbearing age as resident. One
respondent within each household was selected using a set of
predefined criteria as follows: women must be aged 15–49 years;
pregnant women were prioritised over mothers of children aged
under one year, who were prioritised over other eligible women;
and if more than one eligible woman was currently pregnant/
mother of a child aged under 1, the woman most closely related to
the head of the household was interviewed (i.e. wife. daughter.
sister. niece/aunt. daughter-in-law).
Data Collection Instrument
The questionnaire sought to obtain key coverage indicators on
the frequency and timing of ANC attendance, the frequency,
timing and source of IPTp-SP doses and whether each dose was
taken under DOT, and whether an ITN was obtained, by source,
and used during the current/most recent pregnancy; to under-
stand women’s knowledge of malaria in pregnancy in relation to
use of IPTp and ITNs; and to determine whether HIV status alters
behaviour patterns. A composite malaria knowledge score was
created based on the cumulative score of correct responses in
relation to source of malaria (mosquitoes), consequences of malaria
in pregnancy to mother (anaemia) and unborn child (miscarriage,
low birth weight, premature birth, stillbirth) and of methods to
prevent malaria in pregnancy (e.g. IPTp, nets and/or ITNs). HIV
status was self-reported, and additional indirect questions about
Access to Malaria Prevention at ANC in Kenya
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recognition and use of cotrimoxazole and history of episodes of
opportunistic infections associated with HIV were included. Self-
reported IPTp, ITN and ANC practices, including HIV testing
and results, were compared with data contained in ANC cards
where available. Recording of household assets to develop a
wealth index and observation of household ITNs in situ was also
performed. Principal components analysis was used to construct a
wealth index to assess socio-economic status (SES) [28,29] using
household characteristics such as education of the household head,
number of sleeping rooms, floor materials, source of drinking
water, type of toilet facilities, household ownership and a range of
household assets.
The questionnaire was translated and back translated to ensure
accuracy of translation of concepts and variables, and then pre-
tested. Interviewers were trained to conduct the interviews in the
two most commonly spoken local languages, Dholuo and
Kiswahili.
Analysis Framework
The concept of intervention effectiveness as described by
Vlassoff and Tanner showed how the translation of the efficacy
of a disease control tool into community effectiveness was
dependent on coverage, diagnostic accuracy and the compliance
of users and providers [30]. More recently this concept has been
adapted for delivery of interventions through the health system
[21,22,31,32] and used as a health systems effectiveness framework
by the malERA consultative group [33]. We adapted this concept
specifically for the delivery of IPTp and ITNs through ANC to
measure delivery system effectiveness using household data to
identify critical points in the delivery system that were ineffective
(Figure 1). We then explored the predictors of effectiveness at
critical points of weakness identified in the delivery pathway.
Data Processing and Analysis
Data from the household surveys were collected on personal
digital assistants (PDAs). All analyses were adjusted for the survey
design, clustering of households and sample weights using STATA
11.
Socio-demographic characteristics of pregnant and recently
pregnant women were described and compared. Proportions of
women accessing ANC, receiving each dose of SP by source and
the timing of each dose, and receiving ITNs by source were
quantified among both groups of women. The indicator for ITN
use among pregnant women was the proportion of pregnant
women who reported having used an ITN the night before the
survey [34,35], and for recently pregnant women the indicator
used was the proportion of women who reported having used an
ITN regularly during the most recent pregnancy [36,37].
The systems effectiveness analysis was undertaken using recently
pregnant women and excluded HIV positive women with
documented use of cotrimoxazole. Systems effectiveness was
defined as the proportion of women attending ANC who reported
having received at least two doses of SP and used an ITN regularly
during the most recent pregnancy. Two categories of effectiveness
analyses were applied - ‘intermediate process effectiveness’ and
‘cumulative systems effectiveness’ [38]. Intermediate process
effectiveness represents coverage of women at each of the
intermediate steps in the delivery of IPTp, with the addition of
‘used any ITN’ and then ‘used an ITN from ANC’ together with
taking the second dose of IPTp as the final process. Intermediate
process effectiveness was calculated as the number of women who
successfully completed the intermediate process (the numerator) as
a proportion of all women who reached that point in the delivery
system (the denominator) (see formula in Figure 2). An interme-
diate process was classified as ineffective if ,80% women
successfully completed that step. Cumulative systems effectiveness
represents successful coverage of women for each of the
intermediate steps up to that point in the delivery system. The
final step represents the percent of eligible women in the
community that received both interventions and is equivalent to
a cumulative coverage indicator for several indicators (two ANC
visits, two doses of SP (IPTp) and ITN use) that are measured by
DHS.
Intermediate process effectiveness and cumulative systems
effectiveness analyses for IPTp were performed on women
receiving IPTp in an eligible month of gestation (4 to 9 months)
and excluded women who did not receive IPTp and who were
taking cotrimoxazole as documented on ANC cards as per
national policy. This analysis was conducted under two scenarios,
Scenario A where the criteria of receiving IPTp by DOT was not
included, and Scenario B where women received IPTp by DOT
i.e. per policy. The systems effectiveness analysis for ITNs was not
restricted by gestational age as policy states ITNs are to be
delivered to women at their first ANC visit regardless of gestation.
Univariate analyses of potential predictors of receipt of: i) two
doses of SP (with or without DOT); ii) one dose by DOT; and iii)
two doses by DOT (as the three least effective processes identified
in the effectiveness analysis), was conducted using logistic
regression models accounting for survey design, and adjusted
Wald tests were applied to test for associations between predictors
and outcomes. We also explored the predictors of ITN use.
Predictors explored included those known to be important from
previous studies, including: selected individual and household
socio-demographic factors (women’s age, marital status, education,
malaria knowledge using the composite malaria knowledge score,
urban: rural residence and SES); gravidity; having lost a live born
child; number and timing of ANC visits; whether they recently had
an episode of malaria and whether they took medicine for that
episode. Variance inflation factors were examined for all
predictors included in the models to assess potential collinearity.
Potential predictors significant at the 10% level (p,0.1) in the
univariate analyses were included in multivariable logistic regres-
sion models to determine which factors were associated with the
outcomes after accounting for other potential predictors. Interac-
tions between paired predictors were assessed for all predictors
included in the models.
We estimated the potential and actual effectiveness of the
malaria in pregnancy prevention strategy on low birth weight
(LBW) extrapolated to the pregnant population of Nyanza
Province (n = 225,001). We used the protective efficacy of IPTp
on LBW of 29% observed in a meta-analysis of trials which
compared 2-dose IPTp with SP to case management or placebo in
women during their first or second pregnancy (RR 0.71; 95% CI
0.55–0.92) [5], a prevalence of LBW of 12% (unpublished data
from Siaya District Hospital, Ouma personal communication),
and co-coverage with IPTp by DOT and ITNs, using the
following formula [39]:
Number of LBW babies averted~
Target population x Incidence x Protective efficacy x Coverage
Ethical Considerations
The study was approved by the ethical committees of the Kenya
Medical Research Institute (KEMRI) National Ethics Review
Committee, the Liverpool School of Tropical Medicine, the
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London School of Hygiene and Tropical Medicine, and the US
Centers for Disease Control and Prevention in Atlanta. Written
informed consent was obtained from women prior to being
interviewed at home and for adolescents, both parental permission
and assent of the subject was obtained.
Results
Study Population
A total of 961 women of childbearing age were interviewed
(98% response rate) of which 121 (13%) were pregnant and 216
(23%) were mothers of children under one year, i.e. women who
had been pregnant in the previous 12 months, termed ‘recently
pregnant women’. The majority of women in both groups had
attended primary school and were married, and the predominant
ethnic group was Luo. Of the 121 pregnant women, a third were
in their first trimester and the mean gestational age was 5 months
(IQR 3–7) (Table 1). The median age among pregnant women
was 25 years (IQR 22–30) and the majority of these women were
multigravidae, with 88% of women having had 3 or more previous
pregnancies and a median of 4 births (IQR 2–5), and 11% were in
their first pregnancy. Five percent of women already had a child
aged less than 1 year and a third had lost a live born child.
Of the 216 recently pregnant women, almost two-thirds had 3
or more previous pregnancies, with a median of 3 births (IQR 2–
5), and a quarter of women had lost a live born child. About half
the women were aged between 20–29 years, with a median age of
27 years (IQR 21–32). The only characteristics that were
significantly different between the two groups of women was
education (p= 0.05), with twice as many recently pregnant women
having attended secondary education, and gravidity (p,0.0001).
Figure 1. Algorithm for cumulative systems effectiveness of ANC, IPTp and ITN use. ANC: antenatal clinic; CTX: cotrimoxazole; SP:
sulphadoxine-pyrimethamine; DOT: directly observed therapy; IPTp: intermittent preventive treatment; ITN: insecticide treated net.
doi:10.1371/journal.pone.0064913.g001
Figure 2. Formula for calculating intermediate and cumulative
systems effectiveness. Where: N = Total number of target popula-
tion; Nx =Number of women successfully completing step x IE:
Intermediate effectiveness; CE: Cumulative effectiveness.
doi:10.1371/journal.pone.0064913.g002
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Coverage Indicators
Access to ANC and timing of first ANC visit. Among
recently pregnant women, 87% of women reported attending
ANC at least once, 78% at least twice and 34% made 4 or more
visits, with the median number of ANC visits of 3 (IQR 2–4)
(Table 2). Attendance among pregnant women was lower, with a
median number of 2 visits (IQR 1–3), as would be anticipated
given that 70% of women were still in their first or second
trimester. The median month gestation at first ANC visit was 5
months in both groups of women (IQR 3–6 and 4–6 among
pregnant and recently pregnant women respectively).
Number of IPTp doses and timing of receipt. The
coverage analysis shows that just over half of recently pregnant
women reported receiving one dose of SP in any trimester from
Table 1. Socio-demographic characteristics of the respondents.
Socio-demographic data Pregnant women (N=121) Recently pregnant women (N=216) P value
Characteristic n % (95% CI) n % (95% CI)
Trimester
1st trimester 37 30.6
2nd trimester 47 38.8
3rd trimester 37 30.6
Median months gestation 121 5 (IQR 3–7)
Gravidity ,0.0001
Gravida 1 13 10.7 31 14.4
Gravida 2 2 1.7 50 23.3
Gravida 3. 106 87.6 134 62.3
Median number of births 121 4 (IQR 2–5) 215 3 (IQR 2–5)
Age group (15–49) 0.1
15to19yr 14 11.6 28 13.0
20to24yr 38 31.4 54 25.0
25to29yr 38 31.4 51 23.6
30to34yr 20 16.5 40 18.5
35to39yr 7 5.8 31 14.3
40+yr 4 3.3 12 5.6
Median Age 25 (IQR 22–30) 27 (IQR 21–32)
Marital status 0.8
Married 102 84.3 179 82.9
Widowed 8 6.6 12 5.6
Single 11 11.57 25 11.6
Residence 0.7
Rural 114 94.2 201 93.1
Urban 7 5.8 15 6.9
Education level 0.05
None/nursery 3 2.5 5 2.3
Primary 105 86.8 163 75.5
Secondary 12 9.9 46 21.3
College/University 1 0.8 2 0.9
Ethnic Group 0.4
Luo 112 92.6 203 94.0
Luyha 5 4.1 6 2.8
Kalenjin 1 0.8 0 0
Kisii 1 0.8 4 1.9
Other 2 1.7 3 1.4
HIV status (self reported) 6/46 13.0 (5.91,26.37) 8/162 4.9 (2.14,10.97) 0.07
Women with child aged ,1 year 5/107* 4.7 (2.00, 10.4) 216/216 100.0
Women with child aged ,5 years 81/107* 75.7(65.5,83.6) 216/216 100.0
Woman has lost a child 34/108* 31.5 (23.0, 41.3) 54/216 25.0 (19.4,31.6) 0.5
*missing records.
doi:10.1371/journal.pone.0064913.t001
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any source (55%), and 53% if women who received doses in the
first trimester were excluded (Table 2). The majority of women
who reported receiving the first dose of SP at ANC said they
received it under DOT. Only 30% of women reported receiving
the recommended second dose of SP (any trimester from any
source); 28% in an eligible trimester. The majority of women
reported receiving the second dose from ANC and just over half
reported receiving it by DOT. A small proportion of women (9%)
reported receiving three doses of SP.
IPTp coverage by number and timing of ANC
visits. Among recently pregnant women, the mean number of
doses of SP showed a clear trend with increasing number of ANC
visits (p = 0.03) (Figure 3). Similarly, the number of doses of SP
received was associated with gestational age at first ANC visit, with
fewer recently pregnant women receiving a second dose of SP if
they first attended ANC in their second or third trimesters
(p = 0.03) (Figure 4).
ITN use and co-coverage with ITNs and IPTp. Among
pregnant women, 80%reported using an ITN the previous night
whereas 89% of recently pregnant women reported using an ITN
regularly during their most recent pregnancy. Approximately
three quarters of women in both groups reported obtaining the net
Table 2. Key coverage indicators for ANC attendance and malaria in pregnancy interventions among pregnant women and
recently pregnant women.
Coverage Indicators Pregnant Recently pregnant
women (N=121) women (N=216)
n % (95% CI) n % (95% CI)
Number ANC visits
At least one visit 59 48.8 (39.3, 58.3) 188/215* 87.4(83.0,90.9)
At least two visits 38 31.4 (23.1, 41.1) 167/215 77.7(70.9,83.2)
4 or more visits 6 5.0 (2.2, 10.6) 72/215 33.5(27.5,40.1)
Median number of ANC visits 59 2 (IQR 1–3) 188/215 3 (IQR 2–4)
Median gestation at 1st ANC visit 58 5 (IQR 3–6) 187/215 5 (IQR 4–6)
1 dose SP
1 dose (all trimesters, any source) 114/216 52.8(45.9,59.5)
1 dose (all trimesters, any source){ 114/207 55.1(47.9,62.0)
1 dose (4–9 months, any source) 97/184 52.7(44.9,60.4)
Dose 1 at ANC (all trimesters) 104/114 91.2(85.5,94.8)
Dose 1 by DOT at ANC (all trimesters) 79/103 76.7(65.0,85.4)
2 doses SP
2 doses (all trimesters, any source) 62/216 28.7(23.9,34.0)
2 doses (all trimesters, any source){ 62/206 30.1(25.2,35.6)
2 doses (4–9 months, any source) 51/184 27.7(22.3,33.8)
Dose 2 at ANC (all trimesters) 61/62 98.4(88.6,99.8)
Dose 2 by DOT at ANC (all trimesters) 32/59 54.2(40.6,67.2)
3 doses SP
3. doses (all trimesters, any source) 18/216 8.3 (5.3, 12.9)
3. doses (all trimesters, any source){ 18/203 8.9 (5.6,13.7)
ITN use
ITN used last night 97/121 80.2 (72.5, 86.1)
ITN used during last pregnancy 192/215 89.3(83.9,93.0)
ITN sourced from ANC clinic 72/97 74.2 (64.7, 81.9) 145/192 75.5(67.6,82.0)
Co-coverage IPTp* and ITNs
1 dose SP No iptp1, No itn 14 6.8 (3.8, 11.9)
Iptp1, No itn 9 4.4 (2.2, 8.5)
No iptp1, itn 78 37.9(32.2,43.9)
Both iptp1 & itn 105 51.0(43.8,58.1)
2 doses SP No iptp2, No itn 21 10.2 (6.5, 15.7)
Iptp2, No itn 2 1.0(0.2, 3.9)
No iptp2, itn 122 59.5(53.4,65.3)
Both iptp2 & itn 60 29.3(24.2,34.9)
IPTp1: one dose of SP; IPTp2: two doses of SP; DOT: directly observed treatment; ITN: insecticide treated net; ANC: antenatal clinic.
{Excludes women who did not receive IPTp and who were taking cotrimoxazole as documented on ANC cards.
doi:10.1371/journal.pone.0064913.t002
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used in pregnancy from ANC. In terms of co-coverage of ITN use
and IPTp receipt among recently pregnant women, 51% reported
using an ITN and receiving one dose of SP and 29% of using an
ITN and receiving two doses of SP. Whilst few women reported
using neither ITN nor one or two doses of SP, a large proportion
of women reported using an ITN alone in the absence of any SP.
Systems Effectiveness of IPTp and ITN Delivery through
ANC
IPTp with or without DOT. Although 89% (164/185) of
recently pregnant women visited ANC at least once in an eligible
trimester, only 59% received the first dose of SP, and of the 90%
of women who returned for a second ANC visit, only 57%
received a second dose (Table 3). Only 23% (42/185) of women
received the recommended two doses of SP and used an ITN
during pregnancy. There were two intermediate processes in the
delivery system that were ,80% effective - the receipt of one and
two doses of SP. ITN use among women receiving two doses of SP
was 90%.
IPTp given by DOT. With respect to DOT, the cumulative
system effectiveness was even lower, with only 14% (25/185) of
women receiving two doses of SP by DOT and using an ITN
(Table 3; Figure 5). The intermediate processes that were ,80%
effective were, in addition to receipt of one dose of SP (as above),
receiving it under DOT, the receipt of a second dose of SP, and
receiving it under DOT. ITN use among women receiving two
doses of SP by DOT was 100%.
ITNs. Among the 87% (188/215) of recently pregnant
women who attended ANC at least once, 90% reported using
an ITN during their last pregnancy of which 80% were obtained
from ANC (Table 4). Among the 49% (59/121) of pregnant
women who attended ANC at least once, 85% reported using an
Figure 3. Mean number of SP doses received by number of ANC visits among recently pregnant women.
doi:10.1371/journal.pone.0064913.g003
Figure 4. Number of SP doses received by trimester at 1st ANC visit among recently pregnant women.
doi:10.1371/journal.pone.0064913.g004
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ITN the previous night, of which 82% were sourced from ANC.
The difference between the percentage of women who attended
ANC at least once and the percentage of women who attended
ANC but were not using an ANC ITN was 25% among recently
pregnant women and 15% among pregnant women.
Predictors of IPTp Receipt
Two doses of SP. The univariate predictors of recently
pregnant women reporting having received two doses of SP were
timing of ANC visits, not having a child who died prior to this
pregnancy, and malaria knowledge (Table 5). After adjustment, all
three factors were independently associated with receipt of two
doses of SP among recently pregnant women (Table 5). Receipt of
two doses of SP progressively decreased the later a woman made
her first ANC visit (OR 0.20, 95% CI 0.06–0.67 for 7–9 months
gestation). Women were less likely to receive two doses of SP if
they had lost a live born child (OR 0.36, 95% CI 0.14–0.95), and
decreased progressively with lower knowledge of malaria (OR
0.26, 95% CI 0.08–0.83 for the lowest score).
One and two doses of SP by DOT. The univariate
predictors of recently pregnant women reporting having received
one dose of SP under DOT were SES and not having an
unpleasant side effect after taking the dose, and for two doses of SP
by DOT, malaria knowledge score and not having an unpleasant
side effect after taking the previous dose of SP (Table 6). After
adjustment for other potential predictors, low SES and having an
unpleasant side effect after taking the dose remained significantly
associated with receipt of one dose of SP under DOT. Women
from the richest households were more likely to receive one dose of
SP by DOT than women from the poorest households (OR 11.30,
95% CI 1.44–88.57). Women reporting an unpleasant side effect
after taking the first dose of SP such as nausea, vomiting or itchy
skin were less likely to receive the first dose of SP (OR 0.30, 95%
CI 0.11–0.81).Previous experience of having an unpleasant side
effect after the first dose of SP (OR 0.18, 95% CI 0.03–0.90) and
lower knowledge of malaria (OR 0.78, 95% CI 1.11–5.43 for the
lowest score) were independently associated with receipt of two
doses of SP under DOT.
Predictors of ITN Use
The univariate predictors of recently pregnant women not
having used an ITN were person:net ratio and a low malaria
knowledge score. Person:net ratio was also a univariate predictor
among recently pregnant women for not using an ITN and
women taking antimalarials for a malaria episode during her most
recent pregnancy were more likely to use an ITN (Table 7). After
adjustment there were no independent predictors for ITN use in
either group.
Effectiveness of the IPTp strategy
The potential effectiveness of the malaria in pregnancy
prevention strategy among the pregnant population of Nyanza
Province attending ANC, which assumes that recently pregnant
women not taking cotrimoxazole who made one visit in an eligible
trimester (89%; 164/185) and returned to ANC for a second visit
(90%; 60/67) (Table 3) received two doses of SP by DOT and used
an ITN, is 6,264 cases of LBW averted. Based on the reported co-
coverage of two doses of SP by DOT and ITNs among women
attending ANC clinic in Nyanza Province (14%; 25/185), actual
effectiveness was only 1,057 cases of LBW averted. The difference
between potential and actual effectiveness is 5,207 cases of LBW
(95% CI 1,436–8,080) that may have been averted if all women
who attended ANC at least twice in Nyanza Province had received
Figure 5. Cumulative effectiveness of ANC to deliver IPTp and ITNs among recently pregnant women.
doi:10.1371/journal.pone.0064913.g005
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IPTp by DOT and used an ITN, equivalent to 231 (95% CI 64–
359) cases of LBW per 10,000 women.
Discussion
Systems effectiveness analysis was applied to household survey
data to identify critical processes in the delivery of interventions to
pregnant women through ANC that are least effective, providing
useful data to inform strategies to strengthen service delivery in
Nyanza Province. This analytical approach may be applied to
national survey or other household survey data to identify weak
processes in the delivery system for IPTp and ITNs at district or
regional level, and their determinants, to inform regional
adjustments to national strategies. However, it should be noted
that national DHS surveys currently overestimate true IPTp
coverage by the inclusion of women receiving SP in any trimester,
and underestimate coverage in areas of high HIV prevalence
where HIV-positive women are taking cotrimoxazole.
Consistent with the 2008/09 DHS survey [40], over three
quarters of women had made two or more ANC visits at the time
of our survey (DHS, 84%), and the median gestation at first ANC
visit was 5 months (DHS, 5.7 months). In other words, although
women typically start their ANC visits late in the second trimester
of pregnancy, a high proportion attended twice, with each visit in
an eligible gestation to receive SP. However, less than a third of
women who attended ANC at least twice during their most recent
pregnancy received the minimum of two doses of SP as
recommended by national policy, although this figure is likely to
be an underestimate due to low documented use of cotrimoxazole
(14% compared to HIV seroprevalence among pregnant women
participating in a previous study of 21%) [41]. This figure is higher
than the DHS 2008–09 survey (17.2% for Nyanza Province),
which would be anticipated given the ongoing scale-up of the
national programme in the interim period of over one year.
Furthermore, the DHS denominator is women who received IPTp
during the pregnancy for their last live birth in the two years
preceding the survey.
Based on the coverage analysis presented in Table 2, the pattern
of ANC attendance among individual women could not be ruled
out as a possible reason for low coverage with two doses of SP, - for
example women not returning for a second ANC visit. The
intermediate process effectiveness analysis revealed that the most
ineffective processes occurred at the health facility. The high
proportion of women who attended ANC in an eligible gestation
of pregnancy and received their first dose of SP who then made a
second ANC visit (90%) demonstrates that women’s ANC
attendance was not the primary cause for the ineffectiveness of
the IPTp strategy observed. Consistent with other studies, our
findings suggest that health provider practices rather than
women’s ANC attendance are primarily responsible for the
ineffectiveness of the IPTp strategy in this setting [23,42–44].
The two predominant reasons given by women in our study for
not taking the second dose of SP were that they were not informed
a second dose was necessary (33%; 15/45) and that they were not
offered it (31%, 14/45) (data not shown). The finding that health
workers do not always offer IPTp to women at ANC has been
observed in other studies [44,45]. Nevertheless, three quarters of
women said they received the dose(s) by DOT suggesting that,
where IPTp is given, it is predominantly given under DOT.
However, as these data are reported rather than observed
practices, this finding is not conclusive on the practice of IPTp
provision by health workers.
One of the three predictors of receipt of two doses of SP was
timing of women’s first ANC visit, which is influenced by a
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number of factors including pregnancy uncertainties, particularly
during the first trimester, implications of pregnancy disclosure,
interactions with health providers, and the cost of ANC
procedures and the compulsory nature of follow-up appointments
[46]. Women who initiated ANC during their first trimester were
more likely to receive two doses of SP even though they are not
eligible for IPTp at the first visit, suggesting that women’s receiving
the ANC screening package early increases the likelihood of
receiving IPTp on subsequent visits. The timing of ANC visits by
women determines the provision of IPTp by health providers
according to gestational age, as recommended by policy, though
the pattern of health worker behaviour is not always consistent
with policy. Even women who attend ANC at the correct
gestational age are not always offered IPTp [23,44] and this has
been associated with confusion among health workers from
unclear guidelines. In the Tanzania study the authors estimated
that adherence to simplified guidelines by health workers as
recommended by WHO had the potential to increase IPTp
coverage by 20% [23]. In contrast to another study [47], both our
study and the Tanzania study did not identify number of ANC
visits among pregnant women as an independent predictor of
receiving two doses of SP, suggesting that the number of ANC
visits alone is insufficient to ensure uptake in the presence of other
barriers. Whilst we cannot comment on the precise nature of
provider level factors based on this analysis, these factors will be
explored using data collected in health facilities as part of the same
study. Nevertheless, stock out of SP is unlikely to be a primary
issue as stock outs would impact similarly on uptake of both one
and two doses of SP.
The two other individual level factors that predicted non receipt
of two doses of SP, having a child who died and malaria
knowledge score, appear to be consistent with the national DHS
data, which show that IPTp coverage increases with educational
status and wealth quintile [40] if malaria knowledge score and
child died are accepted as proxy indicators for educational status
and SES respectively [48]. However, this finding has not been
consistently observed in previous studies, which show substantial
variation [44,45]. SES was also a predictor of receiving the first
dose of SP under DOT. The second predictor of not receiving
both doses of SP under DOT was having had an unpleasant side
effect after taking the first dose of SP, which has not previously
been reported according to a recent systematic review [20]. This
suggests that health workers are less likely to administer SP by
DOT to women who complain of a previous side effect from SP.
In contrast to IPTp, ITN use among pregnant and recently
pregnant women was high (.80%). While three quarters of
women reported receiving their ITNs from ANC, some women
used an ITN obtained from other sources. It is not possible from
the data to know whether this is because these women were not
offered an ITN at ANC since this was not measured. However,
because most women first attended ANC in their second trimester,
these women may not have been sleeping under ITN during the
first trimester of pregnancy which has been identified as a high risk
period associated with increased risk of LBW, miscarriage and
maternal anaemia [49,50]. Whilst not significant in the multivar-
iate analysis, ITN use was associated with household person: net
ratio which concurs with findings from another study, which
showed that intra-household access to ITNs was the strongest and
most consistent determinant of use among children [51].
Our analysis shows that ANC is a more effective delivery
channel for ITNs than for IPTp in this setting. Whilst this paper
does not present an analysis of the data collected at health
facilities, data from other studies discussed here suggest that stock
outs of SP, absence of cups and clean drinking water for taking SP
by DOT [52], unclear guidelines [23] or confusion among health
workers regarding the guidelines [53,54], and other related health
facility factors hamper delivery of IPTp. It will be important to
evaluate the recent WHO IPTp policy update, which aims to
simplify guidance by recommending the administration of SP to
pregnant women at every scheduled antenatal visit [55] on the
basis of a recent meta-analysis showing that three or more doses of
SP are more effective than two doses [56], to see whether this leads
to an improvement in IPTp uptake. By comparison, ITNs require
a single point of contact with a pregnant woman to secure ITN
uptake, with additional efforts in promotion and education to
ensure women use ITNs from early pregnancy.
The reduced public health impact resulting from the ineffective
delivery of IPTp observed in the study was substantial. Neverthe-
less, our estimate is likely to be an overestimate given that the
protective efficacy of IPTp in third gravidae (or more) women is
less than in primi- and secundi-gravidae, is lower in women
sleeping under ITNs, and that the efficacy estimate used was
observed under trial conditions [5]. This may to some extent be
Table 5. Univariate and multivariate analysis of predictors of receiving two doses of IPTp among recently pregnant women.
Recently pregnant women (n=206)
Determinant n % Crude OR 95% CI P value Adjusted OR 95% CI P value
Timing of 1st ANC visit by trimester 0.04 0.04
0–3 months 21 52.4 1 1
4–6 months 125 35.2 0.49 0.17,1.46 0.49 0.16,1.47
7–9 months 38 18.4 0.21 0.06,0.68 0.20 0.06,0.67
Child died 0.01 0.04
No 157 35.0 1 1
Yes 49 14.3 0.31 0.13,0.75 0.36 0.14,0.95
Malaria knowledge score 0.01 0.04
Score 3 (Highest) 113 38.9 1 1
Score 2 59 22.0 0.44 0.21,0.94 0.47 0.21,1.09
Score 1 (Lowest) 34 14.7 0.27 0.10,0.73 0.26 0.08,0.83
doi:10.1371/journal.pone.0064913.t005
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counterbalanced by the fact that some of the women who did not
receive IPTp by DOT may have taken an effective dose.
The study had several limitations. Reporting bias among
women interviewed, who may feel obliged to under- or over-
report access and usage of interventions for a variety of reasons, is
a weakness of household survey data. To assess potential bias we
measured concordance between reported and documented infor-
mation using women’s ANC cards where available. We found
moderate concordance between reported and ANC card data on
mean number of ANC visits (Kappa score 0.585), and fair
concordance between reported data on receipt of two doses of SP
and use of an ANC ITN with ANC card data on provision of two
doses of SP and an ITN (Kappa score 0.399 and 0.26 respectively)
[57]. These results should be treated with the caveat that relatively
few ANC cards were available and information on IPTp was
available for only 26% of women. There was also potential
selection bias among recently pregnant women; by selecting
women with a child aged under one year, women who had had a
pregnancy loss (miscarriage or stillbirth) may have been excluded
from the recently pregnant group of women, and these women
may have had different health seeking behaviours. Also, the
diminishing numbers in the evaluative sample in the effectiveness
analyses mean the regression analyses have less statistical power
than anticipated. Lastly, the study does not evaluate why health
care providers failed to deliver IPTp to eligible women; this aspect
of the study is to be published separately.
The study highlights an important area for future research, to
develop programme friendly tools and methods to measure
delivery system effectiveness on an ongoing basis to guide local
decision making by programme managers. It will also be
important to evaluate the recently updated WHO policy
recommendation on IPTp with SP, a simplified recommendation
to give IPTp-SP to pregnant women at each scheduled antenatal
care visit released in an effort to improve coverage (see http://
www.who.int/entity/malaria/
iptp_sp_updated_policy_recommendation_en_102012.pdf). In the
future, it will be important to include evidence on delivery system
effectiveness for new drug regimens which replace SP for IPTp, or
new strategies such as intermittent screening and treatment, both
of which will be more complex to deliver. Lastly, efforts to increase
ITN use in early pregnancy should also be encouraged, perhaps
through a combination of encouraging earlier first ANC
attendance and provision of ITNs to women of childbearing age.
Conclusion
In conclusion, we have used household survey data to evaluate
the effectiveness of ANC to deliver ITNs and IPTp to pregnant
women in Nyanza Province in western Kenya, and to identify
which steps in the delivery system are least effective. Our findings
show that women’s timing of ANC attendance, malaria knowl-
edge, and having lost a live born child are important predictors of
uptake of two doses of SP. However, most women attend ANC
with adequate frequency in their second and third trimesters to
receive a minimum of two doses of SP. Missed opportunities at
health facilities appear to account for the greatest losses in strategy
effectiveness, pointing to the need for programme managers to
have access to diagnostic management tools that can detect
bottlenecks in service delivery in a timely manner. This represents
a considerable lost opportunity to improve the health outcomes in
mothers and children with two of the most cost effective health
interventions available in sub-Saharan Africa, with consequent
economic savings to households and health services.
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Table 7. Univariate and multivariate analysis of predictors of using an ITN among pregnant women and recently pregnant women.
Pregnant women (n=121) Recently pregnant women (n=215)
Determinant n %
Crude
OR
95%
CI
P
value
Adjusted
OR
95%
CI
P
value n %
Crude
OR
95%
CI P value
Adjusted
OR
95%
CI
P
value
Took medicine for
malaria
NS 0.007 0.6
No 13 69.2 1 1
Yes 99 93.9 6.89 1.76,27.00 1.77 0.15,20.31
Malaria knowledge
score
0.05 0.90 NS
Score 3 (Highest) 49 87.8 1 1
Score 2 36 77.8 0.49 0.20, 1.17 0.86 0.15,
4.83
Score 1 (Lowest) 36 72.2 0.36 0.16, 0.81 0.66 0.11,
4.00
Person : Net ratio 0.07 0.06 0.01 0.2
,2 22 95.4 1 1 22 100 na na
2–,4 48 100 na na 119 99.2 1 1
4+ 36 72.2 0.12 0.01,1.19 0.12 0.01,1.10 53 86.8 0.06
0.01,0.48 0.21 0.02,2.40
na–not available.
doi:10.1371/journal.pone.0064913.t007
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